Number of biopharmaceuticals approved Japan 2013-2022
In 2022, a total of 24 biopharmaceuticals were newly approved in Japan, down from 24 in the previous year. Biological medicines accounted for around 44 percent of the total new molecular entities (NME) approved in Japan in 2022. Biopharmaceuticals include a wide range of medical drugs produced from living organisms using biotechnology.